Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Women in science: achievements and ambitions

Delanerolle G. et al, (2021), British Journal of Neuroscience Nursing, 17, 13 - 16

Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial.

ELFIN trial investigators group None., (2019), Lancet, 393, 423 - 433

Enteral lactoferrin to prevent infection for very preterm infants: the ELFIN RCT.

Griffiths J. et al, (2018), Health Technol Assess, 22, 1 - 60

Summary Protocol for a Multi-Centre Randomised Controlled Trial of Enteral Lactoferrin Supplementation in Newborn Very Preterm Infants (ELFIN).

The ELFIN Trial Investigators Group None., (2018), Neonatology, 114, 142 - 148

Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial.

Azzopardi D. et al, (2016), Lancet Neurol, 15, 145 - 153

Anticonvulsant effect of xenon on neonatal asphyxial seizures.

Azzopardi D. et al, (2013), Arch Dis Child Fetal Neonatal Ed, 98, F437 - F439

Include forthcoming?